Testing effectiveness (Phase 2)Active Not RecruitingNCT05622318
What this trial is testing
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Who this might be right for
Graft-versus-host Disease
Medical College of Wisconsin 56